KB
Insider selling
Kelly Brady sold $291 of Seres Therapeutics, Inc. (MCRB) stock
Kelly Brady sold 64 shares of MCRB stock worth $291, per an SEC Form 4 filed Aug 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 15, 2026, 3 days before it was made public.
MCRB has moved -10.4% since the trade date, from $4.54 to $4.07 (Sep 21, 2026 close).
- Traded
- Aug 15, 2026
- Disclosed
- Aug 18, 2026
- Filing delay
- 3 days
- Price since
- -10.4%
- Source
- SEC Form 4
More MCRB insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.